Markets:

Overview

News

Currencies

International

Treasuries

Quest Diagnostics (NY:DGX)

189.35 +2.74 (+1.47%)

Streaming Delayed Price Updated: 10:49 AM EDT, May 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Black and Hispanic Communities Are Lagging in Getting Vaccinated. How These Organizations Are Trying to Change That

September 23, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Topics Death

Learn More About Quest’s Commitment to Patients, Clients, Employees and Communities by Reading the Company’s Annual Corporate Responsibility Report

September 21, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Instead of Buying Dogecoin, Invest in These 3 Companies That Are Bullish on Blockchain Technology ↗

September 16, 2021

These businesses have exposure to blockchain technology and they're safer options than buying crypto directly.

Via The Motley Fool

Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates

September 14, 2021

Via FinancialNewsMedia

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗

August 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test ↗

September 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

Quest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests ↗

September 09, 2021

Since Quest Diagnostics Incorporated (NYSE: DGX) reported its Q2 FY21 financial results, COVID-19 molecular testing volumes were stronger than anticipated through the...

Via Benzinga

Underwhelming: Tepid Jobs Data Could Add New Variable To Fed Policy Equation ↗

September 03, 2021

That hissing noise you hear is the air being let out of the market’s tires after an epically disappointing August jobs report. The Delta variant seems to be sinking its...

Via Benzinga

Topics Economy

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

September 01, 2021

Rosenblatt raised Ambarella, Inc. (NASDAQ:AMBA) p...

Via Benzinga

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

Quest Diagnostics, eMed Team Up To Offer COVID-19 Rapid Antigen Testing At Workplaces ↗

August 11, 2021

Telehealth company eMed and Quest Diagnostics Inc (NYSE: DGX) have collaborated for clinician-guided rapid antigen testing for COVID-19 in...

Via Benzinga

Price To Earnings Ratio Insights For Quest Diagnostics ↗

August 11, 2021

In the current session, Quest Diagnostics Inc. (NYSE:DGX) is trading at $149.29, after a 0.48% gain. Over the past month, the stock increased by 10.83%, and in the...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

Healthcare Services IPO Agiliti Stock Sees Improved Relative Strength ↗

July 30, 2021

Agiliti shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Via Investor's Business Daily

Topics Initial Public Offering

Is This Diagnostics Company a Buy After Blowing Away Earnings Estimates? ↗

July 30, 2021

Quest Diagnostics was the beneficiary of a faster than expected recovery in its base business in the second quarter.

Via The Motley Fool

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

Quest Diagnostics Inc (DGX) Q2 2021 Earnings Call Transcript ↗

July 22, 2021

DGX earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Quest Q2 Earnings Ahead Of Expectation On Recovery Of Non-COVID Business, Issues Mixed FY21 Guidance ↗

July 22, 2021

Quest Diagnostics Incorporated (NYSE: DGX) posted better-than-expected second-quarter results, as vaccinations and the lifting of lockdowns resulted in recovery in its...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

August 17, 2021

Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week...

Via Benzinga

The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO ↗

July 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical...

Via Benzinga

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Quest Diagnostics: Q2 Earnings Insights ↗

July 22, 2021

Shares of Quest Diagnostics (NYSE:DGX) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share rose 123.94% year over year to $3.18,...

Via Benzinga

Earnings Preview: Quest Diagnostics ↗

July 21, 2021

On Thursday, July 22, Quest Diagnostics (NYSE:DGX) will release its latest earnings report. Benzinga's outlook for Quest Diagnostics is included in the following report. What Are...

Via Benzinga

Quest Diagnostics's Earnings: A Preview ↗

July 21, 2021

Quest Diagnostics (NYSE:DGX) will be releasing its next round of earnings this Thursday, July 22. For all of the relevant information, here is your guide for Thursday's Q2...

Via Benzinga

Earnings Scheduled For July 22, 2021 ↗

July 22, 2021

Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter. • MarineMax,...

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.